Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals by Anaïs M J Møller, Jean‐Marie Delaisse, Jacob B Olesen, Troels Bechmann, Jonna S Madsen, Kent Søe

Subjects: Get full text

Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease by Juraj Adamik, G David Roodman, Deborah L Galson

Subjects: Get full text

Cancer‐ and Chemotherapy‐Induced Musculoskeletal Degradation by Kathleen M Sturgeon, Katlynn M Mathis, Connie J Rogers, Kathryn H Schmitz, David L Waning

Subjects: “…TUMOR‐INDUCED BONE DISEASE…”
Get full text

Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone by Marita Westhrin, Toril Holien, Muhammad Zahoor, Siv Helen Moen, Glenn Buene, Berit Størdal, Hanne Hella, Huipin Yuan, Joost D deBruijn, Anton Martens, Richard WJ Groen, Fatima Bosch, Ulf Smith, Anne‐Marit Sponaas, Anders Sundan, Therese Standal

Subjects: Get full text

Modeling the Human Bone–Tumor Niche: Reducing and Replacing the Need for Animal Data by Srinivasa R Rao, Claire M Edwards, James R Edwards

Subjects: Get full text

Chemotherapy‐induced peripheral neuropathy increases nontraumatic fracture risk in breast cancer survivors by Brendan L. McNeish, James K. Richardson, Sarah G. Bell, Daniel G. Whitney

Subjects: “…TUMOR INDUCED BONE DISEASE…”
Get full text

Severe Primary Hyperparathyroidism Caused by Parathyroid Carcinoma in a 13‐Year‐Old Child; Novel Findings From HRpQCT by Nina Lenherr‐Taube, Carol KL Lam, Reza Vali, Amer Shammas, Paolo Campisi, Faisal Zawawi, Gino R Somers, Jennifer Stimec, Ozgur Mete, Andy KO Wong, Etienne Sochett

Subjects: Get full text

Prevalence of Precursory Signs of Atypical Femoral Fractures in Patients Receiving Bone‐Modifying Agents for Bone Metastases: A Cross‐Sectional Study by Takumi Kaku, Yoto Oh, Shingo Sato, Hirotaka Koyanagi, Yuki Funauchi, Takashi Hirai, Masato Yuasa, Yu Matsukura, Toshitaka Yoshii, Tsuyoshi Nakagawa, Satoshi Miyake, Atsushi Okawa

Subjects: Get full text

Rare Diseases That Impersonate One Another: X‐Linked Hypophosphatemia and Tumor‐Induced Osteomalacia, a Retrospective Analysis of Discriminating Features by Joseph DeCorte, Ericka Randazzo, Margo Black, Chase Hendrickson, Kathryn Dahir

Subjects: “…TUMOR‐INDUCED BONE DISEASE…”
Get full text

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia by Iris R. Hartley, Kelly L. Roszko, Xiaobai Li, Karen Pozo, Jamie Streit, Jaydira delRivero, M. Teresa Magone, Michaele R. Smith, Roo Vold, Carl L. Dambkowski, Michael T. Collins, Rachel I. Gafni

Subjects: Get full text

Differential Pain‐Related Behaviors and Bone Disease in Immunocompetent Mouse Models of Myeloma by Marta Diaz‐delCastillo, Danna Kamstrup, Rikke Brix Olsen, Rie Bager Hansen, Thomas Pembridge, Brigita Simanskaite, Juan Miguel Jimenez‐Andrade, Michelle A Lawson, Anne‐Marie Heegaard

Subjects: Get full text

Tumor-induced osteomalacia: A systematic literature review by Noelia Álvarez-Rivas, Gloria Lugo-Rodríguez, Jose Ramón Maneiro, Carlota Iñiguez-Ubiaga, Rafael Benito Melero-Gonzalez, Tania Iglesias-Cabo, Loreto Carmona, Carlos García-Porrúa, Francisco Javier de Toro-Santos

Subjects: Get full text

A Normal FGF23 Does Not Preclude Tumor‐Induced Osteomalacia by Neeharika Nandam, Sadia Ejaz, William Ahrens, Maya Styner

Subjects: Get full text